PLoS ONE
(Jan 2023)
Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen
- Léna Angelo,
- Andrew Vaillant,
- Matthieu Blanchet,
- Patrick Labonté
Affiliations
- Léna Angelo
- Andrew Vaillant
- Matthieu Blanchet
- Patrick Labonté
- Journal volume & issue
-
Vol. 18,
no. 11
WeChat QR code